153 related articles for article (PubMed ID: 16039556)
1. The bad seed in Alzheimer's disease.
Fryer JD; Holtzman DM
Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
3. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model.
Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ
Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481
[TBL] [Abstract][Full Text] [Related]
4. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
[TBL] [Abstract][Full Text] [Related]
5. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
6. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease.
Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM
FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995
[TBL] [Abstract][Full Text] [Related]
7. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.
Simard AR; Soulet D; Gowing G; Julien JP; Rivest S
Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional and fractal analyses of assemblies of amyloid beta protein subtypes [Abeta40 and Abeta42(43)] in canine senile plaques.
Miyawaki K; Nakayama H; Matsuno S; Tamaoka A; Doi K
Acta Neuropathol; 2002 Mar; 103(3):228-36. PubMed ID: 11907802
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease.
Lee JY; Kweon HS; Cho E; Lee JY; Byun HR; Kim DH; Kim YH; Han PL; Koh JY
Neurosci Lett; 2007 Aug; 423(1):82-7. PubMed ID: 17662525
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
13. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques.
Kumar-Singh S
Genes Brain Behav; 2008 Feb; 7 Suppl 1():67-82. PubMed ID: 18184371
[TBL] [Abstract][Full Text] [Related]
14. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
[TBL] [Abstract][Full Text] [Related]
15. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.
Chen G; Chen KS; Knox J; Inglis J; Bernard A; Martin SJ; Justice A; McConlogue L; Games D; Freedman SB; Morris RG
Nature; 2000 Dec 21-28; 408(6815):975-9. PubMed ID: 11140684
[TBL] [Abstract][Full Text] [Related]
16. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D
Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685
[TBL] [Abstract][Full Text] [Related]
17. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
[TBL] [Abstract][Full Text] [Related]
18. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
Lee JY; Friedman JE; Angel I; Kozak A; Koh JY
Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629
[TBL] [Abstract][Full Text] [Related]
19. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.
Bard F; Cannon C; Barbour R; Burke RL; Games D; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Lieberburg I; Motter R; Nguyen M; Soriano F; Vasquez N; Weiss K; Welch B; Seubert P; Schenk D; Yednock T
Nat Med; 2000 Aug; 6(8):916-9. PubMed ID: 10932230
[TBL] [Abstract][Full Text] [Related]
20. Biomedicine. Tauists and beta-aptists united--well almost!
Lee VM
Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
[No Abstract] [Full Text] [Related]
[Next] [New Search]